TY - JOUR
T1 - Expert opinion on COVID-19 vaccines and cladribine tablets in MS
T2 - A plain language summary
AU - Rieckmann, Peter
AU - Centonze, Diego
AU - Giovannoni, Gavin
AU - Hua, Le H
AU - Oreja-Guevara, Celia
AU - Selchen, Daniel
AU - Sørensen, Per Soelberg
AU - Vermersch, Patrick
AU - Wiendl, Heinz
AU - Salloukh, Hashem
AU - Yamout, Bassem
PY - 2023/2
Y1 - 2023/2
N2 - WHAT IS THIS SUMMARY ABOUT?: People with multiple sclerosis (shortened to MS) who are taking cladribine tablets may have concerns about whether they can be vaccinated against COVID-19. This summary details the findings from a previously published article, in which an international committee of 10 MS experts developed recommendations to answer some important questions about COVID-19 vaccines in people with MS (including relapsingremitting or active secondary progressive disease) taking cladribine tablets.WHAT WERE THE RESULTS?: The committee identified 13 recommendations, which were all agreed upon by at least three-quarters (75%) of the 38 voting MS experts. Generally, they recommended that people with MS taking cladribine tablets should be vaccinated for COVID-19 as soon as possible, because the vaccine is thought to be both safe and effective, and vaccine responses were not likely to be affected by cladribine tablets.WHAT DO THE RESULTS MEAN?: Overall, people with MS taking cladribine tablets should receive the COVID-19 vaccine to protect themselves, unless advised differently by their healthcare provider.
AB - WHAT IS THIS SUMMARY ABOUT?: People with multiple sclerosis (shortened to MS) who are taking cladribine tablets may have concerns about whether they can be vaccinated against COVID-19. This summary details the findings from a previously published article, in which an international committee of 10 MS experts developed recommendations to answer some important questions about COVID-19 vaccines in people with MS (including relapsingremitting or active secondary progressive disease) taking cladribine tablets.WHAT WERE THE RESULTS?: The committee identified 13 recommendations, which were all agreed upon by at least three-quarters (75%) of the 38 voting MS experts. Generally, they recommended that people with MS taking cladribine tablets should be vaccinated for COVID-19 as soon as possible, because the vaccine is thought to be both safe and effective, and vaccine responses were not likely to be affected by cladribine tablets.WHAT DO THE RESULTS MEAN?: Overall, people with MS taking cladribine tablets should receive the COVID-19 vaccine to protect themselves, unless advised differently by their healthcare provider.
KW - cladribine tablets
KW - clinical research
KW - COVID-19
KW - lay summary
KW - multiple sclerosis
KW - plain language summary
KW - vaccination
UR - http://www.scopus.com/inward/record.url?scp=85147935135&partnerID=8YFLogxK
U2 - 10.2217/nmt-2022-0027
DO - 10.2217/nmt-2022-0027
M3 - Review
C2 - 36278394
SN - 1758-2024
VL - 13
SP - 5
EP - 13
JO - Neurodegenerative disease management
JF - Neurodegenerative disease management
IS - 1
ER -